Journal of Renal Nutrition
Volume 11, Issue 4 , Pages 212-219 , October 2001

Recombinant human growth hormone in patients with acute renal failure

References 

  1. Conger JD. Interventions in clinical acute renal failure: What are the data?. Am J Kidney Dis. 1995;26:565–576
  2. Spurney RF, Fulkerson WJ, Schwab SJ. Acute renal failure in critically ill patients: Prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med. 1991;19:8–11
  3. Cioffi WG, Ashikaga T, Gamelli RL. Probability of surviving postoperative acute renal failure. Ann Surg. 1984;200:205–211
  4. Woodrow G, Turney JH. Cause of death in acute renal failure. Nephrol Dial Transplant. 1992;7:230–234
  5. Berisa F, Beaman M, Adu D, et al.  Prognostic factors in acute renal failure following aortic aneurysm surgery. Q J Med. 1990;76:689–698
  6. Groeneveld ABJ, Tran DD, VanDerMeulen J, et al.  Acute renal failure in the medical intensive care unit: Predisposing, complicating factors and outcome. Nephron. 1991;59:602–610
  7. Spiegel DM, Ullian ME, Zerbe GO, et al.  Determinants of survival and recovery in acute renal failure patients dialyzed in intensive care units. Am J Nephrol. 1991;11:44–47
  8. Pascual J, Orofino L, Liano F, et al.  Incidence and prognosis of acute renal failure in older patients. J Am Geriatr Soc. 1990;38:25–30
  9. Wheeler DC, Feehally J, Walls J. High risk acute renal failure. Q J Med. 1986;61:977–984
  10. Turney JH, Marshall DH, Brownjohn AM, et al.  The evolution of acute renal failure. Q J Med. 1990;74:83–104
  11. Schaefer JH, Jochimsen F, Keller F, et al.  Outcome prediction of acute renal failure in medical intensive care units. Intensive Care Med. 1991;17:19–24
  12. Abel RM, Beck CH, Abot WM. Improved survival from acute renal failure after treatment with intravenous essential L-amino acids and hypertonic glucose. N Engl J Med. 1973;288:695–699
  13. Baek SM, Makabali GG, Brian-Brown CW, et al.  The influence of parenteral nutrition on the course of acute renal failure. Surg Gynecol Obstet. 1975;141:405–408
  14. Bartlett RH, Mault JR, Dechert RE, et al.  Continuous arteriovenous hemofiltration: Improved survival in surgical acute renal failure?. Surgery. 1986;100:400–408
  15. Mault JR, Dechert RE, Lees P, et al.  Continous arteriovenous hemofiltration: An effective treatment for surgical acute renal failure. Surgery. 1987;101:478–484
  16. Fiaccadori E, Lombardi M, Leonardi S, et al.  Prevalence and clinical outcome associated with malnutrition in acute renal failure: A prospective cohort study. J Am Soc Nephrol. 1999;10:581–593
  17. Ikizler TA, Himmelfarb J. Nutrition in renal failure patients. Adv Ren Replace Ther. 1997;4(Suppl 1):54–63
  18. Feinstein EI, Blumenkrantz MJ, Healy H. Clinical and metabolic responses to parenteral nutrition in acute renal failure: A controlled double-blind study. Medicine. 1981;60:124–137
  19. Chima SC, Meyer L, Hummel C, et al.  Protein catabolic rate in patients with acute renal failure on continuous arteriovenous hemofiltration and total parenteral nutrition. J Am Soc Nephrol. 1993;3:1516–1521
  20. Ikizler TA, Green JH, Wingard RL, et al.  Nitrogen balance in acute renal failure (ARF) patients. J Am Soc Nephrol. 1995;6:466; (abstr)
  21. Kopple JD. The nutrition management of the patient with acute renal failure. JPEN J Parenter Enteral Nutr. 1996;20:3–12
  22. Reaich D, Grewal M, Price SR, et al.  Catabolism in acute renal failure: Evidence for stimulation of the ubiquitin-proteasome system and activation of branched chain ?-ketoacid dehydrogenase. J Am Soc Nephrol. 1994;5:953; (abstr)
  23. Horl WH, Heidland A. Enhanced proteolytic activity-cause of protein catabolism in acute renal failure. Am J Clin Nutr. 1980;33:1423–1427
  24. Russell-Jones DI, Umpleby M. Protein anabolic action of insulin, growth hormone and insulin-like growth factor I. Eur J Endocrinol. 1996;135:631–642
  25. Chan W, Valerie KC, Chan JCM. Expression of insulin-like growth factor in uremic rats: Growth hormone resistance and nutritional intake. Kidney Int. 1993;43:790–795
  26. Tonshoff B, Eden S, Weiser E, et al.  Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma binding protein in experimental uremia. Kidney Int. 1994;45:1085–1092
  27. Hammerman MR, Miller SB. Therapeutic use of growth factors in renal failure. J Am Soc Nephrol. 1994;5:1–11
  28. Ponting GA, Ward HC, Halliday D, et al.  Protein and energy metabolism with biosynthetic growth hormone in patients on full intravenous nutritional support. JPEN J Parenter Enteral Nutr. 1990;14:437–441
  29. Lehner JA, Jauch KW, Berger G, et al.  A multicentre study of the dose response effect of human recombinant GH on cumulative nitrogen balance in patients after major abdominal surgery. Ann Surg. 1992;208:6–15
  30. Wilmore DW, Moylan JA, Bristow BF, et al.  Anabolic effects of growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet. 1974;138:875–884
  31. Zeigler TR, Young LS, Ferrari-Baliviera E, et al.  Use of hGH combined with nutritional support in a critical care unit. JPEN J Parenter Enteral Nutr. 1990;14:574–581
  32. Voerman HJ, Van Schinjindel RMS, Groeneveld ABJ, et al.  Effects of recombinant growth hormone in patients with severe sepsis. Ann Surg. 1992;216:648–688
  33. Mulligan K, Grunfeld C, Hellerstein MK, et al.  Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metabol. 1993;77:956–962
  34. Druml W. Nutritional support in acute renal failure. In:  Mitch WE,  Klahr S editor. Nutrition and the Kidney. Boston, MA: Little, Brown; 1993;p. 314
  35. Fine RN. Growth hormone and the kidney: The use of recombinant human growth hormone (rhGH) in growth-retarded children with chronic renal insufficiency. J Am Soc Nephrol. 1991;1:1136–1145
  36. Tanner JM, Hughes PCR, Whitehouse RH. Comparative rapidity of response of height, limb muscle and limb fat to treatment with human GH in patients with and without GH deficiency. Acta Endocrinol (Copenh). 1977;184:681–696
  37. Cheek DB, Hill DE. Muscle and liver cell growth: Role of hormone and nutritional factors, Fed Proc. 1970;29:1503–1509
  38. Horber FF, Haymond MW. Human growth hormone prevents the protein catabolic side effects of prednisolone in humans. J Clin Invest. 1990;86:265–672
  39. Fryburg DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol. 1991;260:E499–E504
  40. Mehls O, Ritz E, Hunziker EB, et al.  Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int. 1988;33:45–52
  41. Humes HD, Cieslinski DA, Coimbra TM, et al.  Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal failure. J Clin Invest. 1989;84:1757–1761
  42. Gore DC, Honeycutt D, Jahoor F, et al.  Effect of exogenous growth hormone on whole body and isolated limb protein kinetics in burned patients. Arch Surg. 1991;126:38–42
  43. Zhang Y, Proenca R, Maffei M, et al.  Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425–432
  44. Florkowski DM, Collier GR, Zimmet PZ, et al.  Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency. Clin Endocrinol. 1996;45:769–773
  45. Al-Shoumer KAS, Anyaoku V, Richmond W, et al.  Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Clin Endocrinol. 1997;47:153–159
  46. Gill MS, Toogood AA, O'Neill PA, et al.  Relationship between growth hormone (GH) status, serum leptin and body composition and GH deficient elderly subjects. Clin Endocrinol. 1997;47:161–167
  47. Berneis K, Vosmeer S, Keller U. Effects of glucocorticoids and of growth hormone on serum leptin concentrations in man. Eur J Endocrinol. 1996;135:663–665
  48. Stenvinkel P, Heimburger O, Lonnqvist F. Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant. 1997;12:1321–1325
  49. Stenvinkel P. Leptin—A new hormone of definite interest for the nephrologist. Nephrol Dial Transplant. 1998;13:1099–1101
  50. Takala J, Ruokenen E, Webster N, et al.  Increased mortality associated with growth hormone treatment in critically ill patients. N Engl J Med. 1999;341:785–792
  51. Gamrin L, Essen P, Hultman E, et al.  Protein-sparing effect in skeletal muscle of growth hormone treatment in critically ill patients. Ann Surg. 2000;231:577–586
  52. Barry MC, Mealy K, O'Neill S, et al.  Nutritional, respiratory and physiological effects of recombinant human growth hormone in patients undergoing abdominal aortic aneurysm repair. JPEN J Parenter Enteral Nutr. 1999;23:128–135
  53. Bettany GE, Camacho-Hubner C, Obeid O, et al.  Metabolic effects of adjuvant recombinant growth hormone in patients with continuing sepsis receiving parenteral nutrition. JPEN J Parenter Enteral Nutr. 1998;22:199–205
  54. Jackson NC, Carroll PV, Russell-Jones DI, et al.  Effects of glutamine supplementation, GH and IGF-1 on glutamine metabolism in critically ill patients. Am J Physiol Endocrinol Metab. 2000;278:E226–E233
  55. Ramirez RJ, Wolf SE, Barrow RE, et al.  Growth hormone treatment in pediatric burns: A safe therapeutic approach. Ann Surg. 1998;228:439–448
  56. Wilmore DW. Impediments to the successful use of anabolic agents in clinical care. JPEN J Parenter Enteral Nut. 1999;23(suppl):S210–S213

☆ †Division of Nephrology, Departments of Preventative Medicine and Medicine, Vanderbilt University Medical Center, Nashville, TN.

☆☆ Address reprint requests to Jonathan Himmelfarb, MD, Division of Nephrology, Maine Medical Center, 22 Bramhall St, Portland, ME 04102. E-mail: himmej@mmc.org

PII: S1051-2276(01)70040-4

doi: 10.1016/S1051-2276(01)70040-4

Journal of Renal Nutrition
Volume 11, Issue 4 , Pages 212-219 , October 2001

Article Tools